The iShares Biotechnology ETF is the default large-cap vehicle for the sector. It is market-cap weighted, which concentrates the fund in cash-generative incumbents rather than spreading capital across clinical-stage names.
The ETF itself is a bond fund that tracks a market of investment-grade U.S. agency mortgage-backed securities, meaning pools of home loans packaged into bonds and issued or guaranteed by Fannie Mae, Freddie Mac, and Ginnie Mae.
I always wanted to be an inventor. That's when I started really thinking about how I could bring some extra money in, but without sacrificing that safety net that I had built at my job.
"This is a system shock," says Nigel Green, CEO of deVere Group. "You have a material energy supply disruption and a structural shift toward fragmentation."
The U.S. and its allies have expended a great deal of their arsenal in the past few years. It simply does not matter if there's a peace deal tomorrow, because those weapons must be stockpiled again and then some.
The iShares U.S. Treasury Bond ETF holds only U.S. Treasury notes and bonds across the maturity curve, providing the cleanest expression of flight-to-quality stability in a single ticker. Credit risk is effectively zero because every holding carries the full faith and credit of the U.S. government.
The fund blends high yield corporate bonds, senior loans, and debt tranches of U.S. collateralized loan obligations (CLOs) into a single actively managed portfolio, aiming to deliver income that beats the broad bond market while keeping volatility lower than any single segment on its own.